Medipharm Labs Corp
F:MLZ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Medipharm Labs Corp
F:MLZ
|
CA |
|
Exide Industries Ltd
NSE:EXIDEIND
|
IN |
|
Jardine Cycle & Carriage Ltd
F:CYC
|
SG |
|
C
|
Columbus McKinnon Corp
F:VC3
|
US |
|
S
|
Salesforce Inc
XETRA:FOO
|
US |
|
Advanced Drainage Systems Inc
F:6DA
|
US |
|
Creative Technology Ltd
F:CTL
|
SG |
|
A
|
ASN Broker PCL
SET:ASN
|
TH |
|
B
|
Buffalo Coal Corp
XTSX:BUF
|
ZA |
|
C
|
Carlisle Companies Inc
SWB:CLE
|
US |
|
Shenzhou International Group Holdings Ltd
HKEX:2313
|
CN |
|
5
|
51job Inc
F:IWQ
|
CN |
|
J
|
Jet2 PLC
XMUN:DG1
|
UK |
|
J
|
JAFCO Group Co Ltd
XMUN:JAF
|
JP |
|
H
|
Heidelberg Pharma AG
XMUN:HPHA
|
DE |
|
F
|
Funko Inc
F:FU2
|
US |
|
H
|
Hargreaves Lansdown PLC
DUS:DMB
|
UK |
|
Valley National Bancorp
NASDAQ:VLY
|
US |
|
Fox Corp
F:FO5B
|
US |
|
A
|
Avicanna Inc
OTC:AVCNF
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MLZ's stock price target?
Not Available
MLZ does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Medipharm Labs Corp?
Projected CAGR
0%
Over the last 6 years, the compound annual growth rate for Revenue has been -16%. The projected CAGR for the next 2 years is 0%.
What is the Gross Profit forecast for Medipharm Labs Corp?
Projected CAGR
17%
Over the last 6 years, the compound annual growth rate for Gross Profit has been -19%. The projected CAGR for the next 2 years is 17%.